Trial
NCT01659138
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Ulcerative Colitis
Intervention
SAR339658
Why stopped
Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-13